98%
921
2 minutes
20
Endothelial dysfunction is a known consequence of chronic hyperglycemia and a major pathogenic factor for microvascular diseases such as diabetic retinopathy. The effect and exposure period to acute hyperglycemia on the vascular endothelium, and its ability to recover from such exposure is less well understood. Here, we used an isolated perfused eye preparation to study the effect of acute hyperglycemia on the ocular microvascular endothelium of normoglycemic and 1-, 2-, 3-, and 4-week streptozotocin (STZ)-induced diabetic rats. The acetylcholine (Ach)-induced vasodilatory response was measured during sequential exposure to 6 mM (normoglycemic), 12 mM (mild hyperglycemic), 24 mM (hyperglycemic) and then again to 6 mM (normoglycemic) perfusates. Eyes were then processed histologically for examination of capillary density, capillary diameter, pericyte distribution, endothelial nitric oxide synthase (eNOS) distribution and accumulation of advanced glycated end products (AGEs). Ach responses were significantly enhanced in normoglycemic, 1-,2-, 3- and 4-week diabetic eyes after less than 2-h of high glucose (24 mM) exposure. Upon return to normoglycemia, Ach-induced responses in 1-, 2- and 3-week diabetic eyes were comparable with normoglycemic eyes. In the 4-week diabetic eyes, Ach-induced vasodilatory responses remained significantly enhanced despite restoration of normoglycemia. Capillary density and capillary diameter did not change significantly after 1-, 2-, 3- and 4-weeks of STZ-induced diabetes. Pericyte distribution significantly increased in all vascular layers of the 3- and 4-week diabetic eyes. eNOS immunoreactivity significantly increased in 1-week diabetic eyes. Significant AGEs immunolabelling was detected in the vascular basement membrane and intracellularly in 1-week STZ rats. These findings suggest that whilst endothelial function can recover after short term hyperglycemia, prolonged exposure (≥ 4 weeks) results in incomplete restoration, indicating a potential transition towards irreversible dysfunction.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368113 | PMC |
http://dx.doi.org/10.1038/s41598-025-12612-4 | DOI Listing |
J Ophthalmic Vis Res
September 2025
Faculty of Medicine, Padjadjaran University, Bandung, Indonesia.
Purpose: To assess the effect of empagliflozin on the expression of SGLT-2 and GLUT-1 in the chorioretina of streptozotocin-induced diabetic rats.
Methods: An experimental study was performed on Wistar rats. After a 2-week adaptation period, the rats were allocated to one of four groups.
Clin Ophthalmol
September 2025
Internal Medicine Department, Medical Faculty, Universitas Brawijaya, Malang, Indonesia.
Purpose: To evaluate macular vessel density using clinical parameters in patients with type 2 diabetes mellitus (DM) without retinopathy.
Patients And Methods: This cross-sectional study enrolled 32 participants (63 eyes) aged 40-60 years who met the inclusion criteria. Group 1 included 32 eyes of type 2 DM, whereas the rest had no DM.
Nat Aging
September 2025
Aging Biomarker Consortium (ABC), Beijing, China.
The global surge in the population of people 60 years and older, including that in China, challenges healthcare systems with rising age-related diseases. To address this demographic change, the Aging Biomarker Consortium (ABC) has launched the X-Age Project to develop a comprehensive aging evaluation system tailored to the Chinese population. Our goal is to identify robust biomarkers and construct composite aging clocks that capture biological age, defined as an individual's physiological and molecular state, across diverse Chinese cohorts.
View Article and Find Full Text PDFJMIR Med Inform
September 2025
Global Health Economics Centre, Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Background: Artificial intelligence (AI) algorithms offer an effective solution to alleviate the burden of diabetic retinopathy (DR) screening in public health settings. However, there are challenges in translating diagnostic performance and its application when deployed in real-world conditions.
Objective: This study aimed to assess the technical feasibility of integration and diagnostic performance of validated DR screening (DRS) AI algorithms in real-world outpatient public health settings.
Diabetes Care
September 2025
Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA.
Objective: This study aimed to evaluate the diabetic eye disease screening continuum at two academic centers and identify its barriers.
Research Design And Methods: We analyzed health records from the University of California, San Francisco and University of California, Irvine to identify primary care patients needing diabetic eye screening. We tracked referrals, screenings, diagnoses, and treatments to evaluate predictors and the impact of an automated referral system.